Xilio Therapeutics (XLO) Ending Cash Balance (2020 - 2026)
Xilio Therapeutics (XLO) posted Ending Cash Balance of $137.86 million for Q2 2026, up 11.8% from $123.35 million a year earlier but down 9.4% from the prior quarter.
Powered by 
Analysis
Xilio Therapeutics (XLO) Ending Cash Balance (2020 - 2026) Analysis & Trends
For FY2025, Xilio Therapeutics' Ending Cash Balance came in at $139.34 million, up 144.1% from FY2024.
- Annual Ending Cash Balance shows a four-year compound annual growth rate of -8.6% (FY2021 to FY2025).
- In prior years, Xilio Therapeutics' Ending Cash Balance was $57.07 million in FY2024 (+23.3%), $46.29 million in FY2023 (-62.0%), $121.95 million in FY2022 (-38.9%) and $199.61 million in FY2021.
- Quarterly Ending Cash Balance has run from a low of $36.74 million in Q1 2024 to a high of $199.61 million in Q4 2021 over five years.
- On a year-over-year basis, Ending Cash Balance has increased in each of the last eight quarters, with growth averaging 65.6% over the last eight quarters.
- The strongest year-over-year quarter for Ending Cash Balance in the past five years was Q1 2025, with growth of 147.3%; the weakest was Q4 2023, with a decline of 62.0%.
- According to Business Quant data, Ending Cash Balance for the three prior quarters was $152.15 million (Q1 2026), $139.34 million (Q4 2025) and $105.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Xilio Therapeutics | 167.94 Mn | -378.15 Mn | - | 1.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.83 Mn |
| Jun 30, 2026 | 137.86 Mn |
| Mar 31, 2026 | 152.15 Mn |
| Dec 31, 2025 | 139.34 Mn |
| Sep 30, 2025 | 105.57 Mn |
| Jun 30, 2025 | 123.35 Mn |
| Mar 31, 2025 | 90.86 Mn |
| Dec 31, 2024 | 57.07 Mn |
| Sep 30, 2024 | 63.03 Mn |
| Jun 30, 2024 | 76.72 Mn |
| Mar 31, 2024 | 36.74 Mn |
| Dec 31, 2023 | 46.29 Mn |
| Sep 30, 2023 | 61.35 Mn |
| Jun 30, 2023 | 76.96 Mn |
| Mar 31, 2023 | 94.84 Mn |
| Dec 31, 2022 | 121.95 Mn |
| Sep 30, 2022 | 140.70 Mn |
| Jun 30, 2022 | 160.96 Mn |
| Mar 31, 2022 | 178.51 Mn |
| Dec 31, 2021 | 199.61 Mn |
API Access
Xilio Therapeutics Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=XLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "XLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=XLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();